Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-08-18Clinical Trial Update: Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer [Phase 2]
Phase 2 clinical trial update evaluating radiation therapy with androgen suppression in patients with prostate cancer.
-
CLINICAL_TRIALS trial_result · 2023-08-18Clinical Trial Update: Hypofractionated Whole-Pelvis Radiotherapy (WPRT) vs Conventionally-Fractionated WPRT in Prostate Cancer [Phase 2]
Phase 2 trial comparing hypofractionated whole-pelvis radiotherapy to conventionally-fractionated radiotherapy in prostate cancer is active …
-
CLINICAL_TRIALS withdrawal · 2023-08-15Clinical Trial Update: Pioglitazone and Insulin Resistance in ADT [Phase 3]
Phase 3 trial evaluating pioglitazone for insulin resistance in the context of androgen deprivation therapy for prostate cancer has been wit…
-
CLINICAL_TRIALS trial_result · 2023-08-09Clinical Trial Update: Comparing the Efficacy and Safety of Rezvilutamide+ADT+Docetaxel Versus Rezvilutamide +ADT in the mHSPC [Phase 3]
Phase 3 trial comparing rezvilutamide with ADT and docetaxel versus rezvilutamide with ADT in metastatic hormone-sensitive prostate cancer i…
-
CLINICAL_TRIALS trial_result · 2023-08-07Clinical Trial Update: A Phase 2 Trial of Darolutamide as a Prostate-Specific Membrane Antigen (PSMA) Expression Enhancer in Patients With Localized Prostate Cancer [Phase 2]
Phase 2 trial exploring darolutamide as a PSMA expression enhancer in localized prostate cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: Reolysin Combined With Docetaxel and Prednisone or Docetaxel and Prednisone Alone in Metastatic Castration Resistant Prostate Cancer [Phase 2]
Phase 2 trial evaluating Reolysin with docetaxel and prednisone versus docetaxel and prednisone alone in metastatic castration-resistant pro…
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: Androgen Suppression and Radiation With/Out Docetaxel in High-Risk Localized Prostate Cancer [Phase 3]
Phase 3 trial investigating androgen suppression and radiation with or without docetaxel in high-risk localized prostate cancer was terminat…
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: Docetaxel and Prednisone With/Out OGX-011 in Recurrent or Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy [Phase 2]
Phase 2 clinical trial evaluating docetaxel and prednisone with or without OGX-011 in recurrent or metastatic prostate cancer after progress…
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: Study to Compare the Effects of Drug Darolutamide and Drug Enzalutamide on Physical Function, Including Balance and Daily Activity, in Patients With Castration-resistant Prostate Cancer (CRPC) [Phase 2]
Phase 2 trial comparing darolutamide and enzalutamide in castration-resistant prostate cancer; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: SB939 in Treating Patients With Recurrent or Metastatic Prostate Cancer [Phase 2]
Phase 2 clinical trial update for SB939 in recurrent or metastatic prostate cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: Sorafenib in Treating Patients With Metastatic or Recurrent Prostate Cancer [Phase 2]
Phase 2 trial update evaluating sorafenib in metastatic or recurrent prostate cancer has completed.
-
CLINICAL_TRIALS withdrawal · 2023-08-04Clinical Trial Update: Study of Pembrolizumab (MK-3475) Plus Docetaxel Versus Placebo Plus Docetaxel in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-921/KEYNOTE-921)-China Extension [Phase 3]
Phase 3 trial (KEYNOTE-921) evaluating pembrolizumab with docetaxel versus placebo with docetaxel in chemotherapy-naïve metastatic castratio…
-
CLINICAL_TRIALS trial_result · 2023-08-03Clinical Trial Update: Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene [Phase 1, Phase 2]
Phase 1/2 clinical trial studying A166 in patients with various HER2-expressing or HER2-amplified cancers has completed.
-
CLINICAL_TRIALS trial_result · 2023-08-02Clinical Trial Update: Study of the Efficacy, Safety and Quality of Life After TOOKAD® Soluble (VTP) for Intermediate Risk Prostate Cancer. [Phase 2]
Phase 2 study evaluating efficacy, safety, and quality of life after VTP treatment with TOOKAD Soluble for intermediate-risk prostate cancer…
-
CLINICAL_TRIALS trial_result · 2023-08-02Clinical Trial Update: FACBC Outcomes for Post Prostatectomy [Phase 2, Phase 3]
Phase 2/3 clinical trial update on FACBC for prostate cancer after prostatectomy has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-08-02Clinical Trial Update: Decision Aids to Improve Knowledge in Patients With Prostate Cancer [NA]
Completed clinical trial evaluating decision aids to improve knowledge in patients with prostate cancer; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: Leuprolide Acetate 3.75 mg Depot Injection for Patients With Advanced Prostate Cancer [Phase 3]
A Phase 3 trial update for Leuprolide Acetate 3.75 mg Depot Injection in advanced prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-07-28Clinical Trial Update: Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate [Phase 3]
Phase 3 trial evaluating darolutamide added to standard therapy for localized very high-risk prostate cancer; ongoing status indicating acti…
-
CLINICAL_TRIALS trial_result · 2023-07-27Clinical Trial Update: The Role of 68Ga-PSMA-11 PET (Prostate Specific Membrane Antigen) in Surgery Guidance in Prostate Cancer [Phase 2]
Phase 2 trial update evaluating 68Ga-PSMA-11 PET for guidance in prostate cancer surgery; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2023-07-25Clinical Trial Update: Use of Indocyanine Green in Robotic Prostate Surgeries [Phase 4]
Phase 4 trial update on using indocyanine green in robotic prostate surgeries, with conditions including prostate cancer adenocarcinoma and …
-
CLINICAL_TRIALS trial_result · 2023-07-24Clinical Trial Update: Luteinizing Hormone-Releasing Hormone Agonist Therapy and Iodine I 125 Implant in Treating Patients With Previously Untreated Prostate Cancer [Phase 3]
Phase 3 trial investigating Luteinizing Hormone-Releasing Hormone agonist therapy combined with Iodine-125 implant for previously untreated …
-
CLINICAL_TRIALS trial_result · 2023-07-24Clinical Trial Update: Lidocaine Combined With Sufentanil for Preventing Catheter-related Bladder Discomfort [Phase 4]
Phase 4 clinical trial investigating lidocaine combined with sufentanil to prevent catheter-related bladder discomfort in patients with pros…
-
CLINICAL_TRIALS trial_result · 2023-07-21Clinical Trial Update: Docetaxel and PROSTVAC for Metastatic Castration-Sensitive Prostate Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of docetaxel and PROSTVAC for metastatic castration-sensitive prostate cancer has complete…
-
CLINICAL_TRIALS trial_result · 2023-07-19Clinical Trial Update: 177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer [Phase 2]
Phase 2 clinical trial evaluating a radiolabeled monoclonal antibody (177Lu-J591) in combination with ketoconazole for prostate cancer; resu…
-
CLINICAL_TRIALS research · 2023-07-14Clinical Trial Update: ESK981 in Treating Patients With Metastatic Castrate-Resistant Prostate Cancer [Phase 2]
Phase 2 clinical trial update for ESK981 in metastatic castration-resistant prostate cancer shows completed status with posted results.